Presentation TVT 2013 The Keystone Deflector Device: Technology and Early Clinical Experiences Presenter: Jeffrey Moses June 12, 2013
Presentation Oral Anticoagulation (OAC) and Antiplatelets inA-fib Patients After MI and PCI Presenter: M. Lamberts June 12, 2013
Presentation TVT 2013 Baseline Frailty Status of the "Extreme Risk" Patients in the US CoreValve Trial Presenter: Jeffrey Popma June 12, 2013
Presentation TVT 2013 Best Clinical Practices for Transfemoral TAVR Presenter: Susheel Kodali June 12, 2013
Presentation TVT 2013 Risk Profiling Schemes Used in the US CoreValve Trial Presenter: Steven Yakubov June 12, 2013
Presentation TVT 2013 The Landscape of Dedicated Transfemoral Closure Devices for TAVR Presenter: Eberhard Grube June 12, 2013
Presentation TVT 2013 Columbia University Medical Center (New York, NY) Presenter: Susheel Kodali June 12, 2013
Presentation TVT 2013 Pharmacotherapy Alternatives During and After TAVR: Is There an Optimal Regimen? Presenter: Corrado Tamburino June 12, 2013
Presentation TVT 2013 Defining and Measuring Frailty in Aortic Stenosis Patients: From the Eyeball Test to Objective Tools Presenter: Philip Green June 12, 2013